0000316011-25-000092.txt : 20251126 0000316011-25-000092.hdr.sgml : 20251126 20251126160007 ACCESSION NUMBER: 0000316011-25-000092 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20251125 FILED AS OF DATE: 20251126 DATE AS OF CHANGE: 20251126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LILLY ENDOWMENT INC CENTRAL INDEX KEY: 0000316011 ORGANIZATION NAME: STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 251529907 BUSINESS ADDRESS: STREET 1: 2801 NORTH MERIDIAN STREET CITY: INDIANANAPOLIS STATE: IN ZIP: 46208 BUSINESS PHONE: 3179245471 MAIL ADDRESS: STREET 1: 2801 NORTH MERIDIAN ST CITY: INDIANAPOLIS STATE: IN ZIP: 46208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 4 1 form4-11262025_041101.xml X0508 4 2025-11-25 0000059478 ELI LILLY & Co LLY 0000316011 LILLY ENDOWMENT INC 2801 NORTH MERIDIAN STREET INDIANAPOLIS IN 46208-0068 false false true false 0 Common Stock 2025-11-25 4 S 0 2481 1073.735 D 92357190 D Common Stock 2025-11-25 4 S 0 882 1075.997 D 92356308 D Common Stock 2025-11-25 4 S 0 800 1077.988 D 92355508 D Common Stock 2025-11-25 4 S 0 1260 1079.367 D 92354248 D Common Stock 2025-11-25 4 S 0 651 1080.733 D 92353597 D Common Stock 2025-11-25 4 S 0 1606 1081.90 D 92351991 D Common Stock 2025-11-25 4 S 0 160 1082.933 D 92351831 D Common Stock 2025-11-25 4 S 0 3069 1084.702 D 92348762 D Common Stock 2025-11-25 4 S 0 5604 1086.069 D 92343158 D Common Stock 2025-11-25 4 S 0 6508 1086.941 D 92336650 D Common Stock 2025-11-25 4 S 0 5589 1087.965 D 92331061 D Common Stock 2025-11-25 4 S 0 5284 1088.907 D 92325777 D Common Stock 2025-11-25 4 S 0 1907 1089.854 D 92323870 D Common Stock 2025-11-25 4 S 0 5927 1091.116 D 92317943 D Common Stock 2025-11-25 4 S 0 18254 1092.058 D 92299689 D Common Stock 2025-11-25 4 S 0 9050 1093.164 D 92290639 D Common Stock 2025-11-25 4 S 0 6246 1094.026 D 92284393 D Common Stock 2025-11-25 4 S 0 2083 1094.794 D 92282310 D Common Stock 2025-11-25 4 S 0 1061 1096.329 D 92281249 D Common Stock 2025-11-25 4 S 0 4198 1097.443 D 92277051 D Common Stock 2025-11-25 4 S 0 4639 1098.315 D 92272412 D Common Stock 2025-11-25 4 S 0 6545 1099.485 D 92265867 D Common Stock 2025-11-25 4 S 0 8527 1100.336 D 92257340 D Common Stock 2025-11-25 4 S 0 11854 1101.449 D 92245486 D Common Stock 2025-11-25 4 S 0 7456 1102.346 D 92238030 D Common Stock 2025-11-25 4 S 0 6274 1103.576 D 92231756 D Common Stock 2025-11-25 4 S 0 5196 1104.411 D 92226560 D Common Stock 2025-11-25 4 S 0 2494 1105.32 D 92224066 D Common Stock 2025-11-25 4 S 0 3662 1106.573 D 92220404 D Common Stock 2025-11-25 4 S 0 7794 1107.48 D 92212610 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,073.78 to $1,074.77, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), (20), (21), (22), (23), (24), (25), (26), (27), (28), (29), and (30) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,075.50 to $1,076.47, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,077.64 to $1,078.38, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,078.84 to $1,079.52, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,080.10 to $1,081.00, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,081.36 to $1,082.25, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,082.82 to $1,083.00, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,084.50 to $1,085.45, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,085.50 to $1,086.45, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,086.50 to $1,087.49, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,087.50 to $1,088.48, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,088.50 to $1,089.47, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,089.51 to $1,090.46, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,090.57 to $1,091.55, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,091.58 to $1,092.57, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,092.58 to $1,093.57, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,093.58 to $1,094.53, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,094.65 to $1,095.32, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,095.86 to $1,096.70, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,096.87 to $1,097.86, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,097.87 to $1,098.84, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,098.87 to $1,099.85, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,099.87 to $1,100.83, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,100.87 to $1,101.86, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,101.87 to $1,102.86, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,102.97 to $1,103.96, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,103.97 to $1,104.96, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,104.97 to $1,105.96, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,105.99 to $1,106.98, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,107.00 to $1,107.95, inclusive. This is the first of two Forms 4 filed by the Reporting Person on same date, November 26, 2025, representing transactions #1 through #30 of 33 total transactions. /s/ Ben W. Blanton, Vice President, Secretary and General Counsel, on behalf of Lilly Endowment Inc. 2025-11-26